Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL
Clinical trial NCT04300803 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04300803
- Sponsor
- MorphoSys AG
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.